Literature DB >> 28707586

An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds.

Enrico Zanforlin1, Giuseppe Zagotto1, Giovanni Ribaudo1.   

Abstract

BACKGROUND: Dementias and all related neurodegenerative diseases of the Central Nervous System (CNS) are a current issue arousing a great deal of interest in the international scientific community. This is due to the increasing number of patients suffering from these diseases. These pathologies represent a serious problem, not only concerning the quality of life of the patient, but in addition, the enormous economic efforts that society has to do for their treatment. There are currently a few strategies that are available in order to prevent the progression or to mitigate symptoms of the aforementioned diseases. This consideration is particularly true if we consider the specific pathology of Alzheimer's Disease (AD).
METHODS: We performed a literature search for peer-reviewed articles using different databases, such as PubMed or Scopus, and exploiting different keywords and different logical operators.
RESULTS: Ninety-eight papers were included in the review. Four papers give an overview of the background of the dementias all over the world. The remaining papers are focused on new possibilities of treatment with natural and semi-synthetic compounds for AD.
CONCLUSION: The aim of this review is to give an overview of new and promising natural products and semi-synthetic compounds which could represent a source of "lead compounds" for the development of new potential drugs that could be a valid therapeutic strategy for the treatment of this pathology. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer's disease; CNS; Dementia; beta amyloid; natural products; semi-synthetic compounds.

Mesh:

Substances:

Year:  2017        PMID: 28707586     DOI: 10.2174/0929867324666170712161829

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  6 in total

Review 1.  Multicrossover Randomized Controlled Trial Designs in Alzheimer Disease.

Authors:  Steven E Arnold; Rebecca A Betensky
Journal:  Ann Neurol       Date:  2018-08-29       Impact factor: 10.422

2.  Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer's Disease Agents.

Authors:  Viviana Poliseno; Sílvia Chaves; Leonardo Brunetti; Fulvio Loiodice; Antonio Carrieri; Antonio Laghezza; Paolo Tortorella; João D Magalhães; Sandra M Cardoso; M Amélia Santos; Luca Piemontese
Journal:  Biomolecules       Date:  2021-01-15

Review 3.  A Perspective on Natural and Nature-Inspired Small Molecules Targeting Phosphodiesterase 9 (PDE9): Chances and Challenges against Neurodegeneration.

Authors:  Giovanni Ribaudo; Maurizio Memo; Alessandra Gianoncelli
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-13

4.  Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer's Disease: Formulation Development and Optimization.

Authors:  Debora Santonocito; Giuseppina Raciti; Agata Campisi; Giovanni Sposito; Annamaria Panico; Edy Angela Siciliano; Maria Grazia Sarpietro; Elisabetta Damiani; Carmelo Puglia
Journal:  Nanomaterials (Basel)       Date:  2021-02-03       Impact factor: 5.076

Review 5.  Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist.

Authors:  Giovanni Ribaudo; Alberto Ongaro; Giuseppe Zagotto; Maurizio Memo; Alessandra Gianoncelli
Journal:  ACS Chem Neurosci       Date:  2020-05-28       Impact factor: 4.418

Review 6.  The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders.

Authors:  Priti Tagde; Pooja Tagde; Fahadul Islam; Sandeep Tagde; Muddaser Shah; Zareen Delawar Hussain; Md Habibur Rahman; Agnieszka Najda; Ibtesam S Alanazi; Mousa O Germoush; Hanan R H Mohamed; Mardi M Algandaby; Mohammed Z Nasrullah; Natalia Kot; Mohamed M Abdel-Daim
Journal:  Molecules       Date:  2021-11-24       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.